Неалкохолна масна болест јетре (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Неалкохолна масна болест јетре" in Serbian language version.

refsWebsite

Global rank Serbian rank

14doi.org

2^nd place

4^th place

14nih.gov

4^th place

8^th place

3semanticscholar.org

11^th place

23^rd place

1archive.org

6^th place

5^th place

1easl.eu

low place

1harvard.edu

18^th place

28^th place

1worldcat.org

5^th place

12^th place

1wikipedia.org

low place

1handle.net

102^nd place

266^th place

1hirurgijadrdjokovic.com

low place

archive.org

Lavine, J. E. (2000). „Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study”. J. Pediatr. 136: 734—738. .

doi.org

Eslam, M; Sanyal, AJ; George, J; an international consensus panel. (7. 2. 2020). „MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease.”. Gastroenterology. 158 (7): 1999—2014.e1. PMID 32044314. doi:10.1053/j.gastro.2019.11.312 .
Jensen, Thomas; Abdelmalek, Manal F.; Sullivan, Shelby; Nadeau, Kristen J.; Green, Melanie; Roncol, Carlos; Nakagawa, Takahiko; Kuwabara, Masanari; Sato, Yuka; Kang, Duk-Hee; Tolan, Dean R.; Sanchez-Lozada, Laura G; Rosen, Hugo R.; Lanaspa, Miguel A.; Diehl, Anna Mae; Johnson, Richard J. (2018). „Fructose and Sugar: A Major Mediator of Nonalcoholic Fatty Liver Disease”. HHS Author Manuscripts. 68 (5): 1063—1075. PMC 5893377 . PMID 29408694. doi:10.1016/j.jhep.2018.01.019.
Dulai S., Parambir; Singh, Siddgarth; Petel, Janki; Soni, Meera; Prokop, Larry J.; Younossi, Zobair; Sebastiani, Giada; Ekstedt, Mattias; Hagstrom, Hannes; Nasr, Patrik; Stal, Per; Wong, Vincent Wai-Sun; Kechagias, Stergios; Hultcrantz, Rolf; Loomba, Rohit (2017). „Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: Systematic Review and Meta-analysis”. HHS Author Manuscripts. 65 (5): 1557—1565. PMC 5397356 . PMID 28130788. doi:10.1002/hep.29085.
Anderson, Emma L.; Howe, Laura D.; Jones, Hayley E.; Higgins, Julian P. T.; Lawlor, Debbie A.; Fraser, Abigail (2015). „The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis”. PLOS ONE. 10 (10): e0140908. Bibcode:2015PLoSO..1040908A. PMC 4626023 . PMID 26512983. doi:10.1371/journal.pone.0140908 . .
Estes, Chris; Razavi, Homie; Loomba, Rohit; Younossi, Zobair; Sanyal, Arun J. (2018). „Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease”. Hepatology. 67 (1): 123—133. PMC 5767767 . PMID 28802062. doi:10.1002/hep.29466. .
Hashimoto, Etsuko; Taniai, Makiko; Tokushige, Katsutoshi (2013). „Characteristics and diagnosis of <SCP>NAFLD</SCP>/<SCP>NASH</SCP>”. Journal of Gastroenterology and Hepatology. 28: 64—70. PMID 24251707. S2CID 1986581. doi:10.1111/jgh.12271. .
Karkucinska-Wieckowska, Agnieszka; Simoes, Ines C. M.; Kalinowski, Piotr; Lebiedzinska-Arciszewska, Magdalena; Zieniewicz, Krzysztof; Milkiewicz, Piotr; Górska-Ponikowska, Magdalena; Pinton, Paolo; Malik, Afshan N. (2022). „Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship”. European Journal of Clinical Investigation. 52 (3): e13622. ISSN 1365-2362. doi:10.1111/eci.13622. hdl:10316/103977.
Ahmed, Monjur (2015). „Non-alcoholic fatty liver disease in 2015”. World Journal of Hepatology. 7 (11): 1450—1459. PMC 4462685 . PMID 26085906. doi:10.4254/wjh.v7.i11.1450 .
Filozof, Claudia; Goldstein, Barry J.; Williams, Richard N.; Sanyal, Arun (2015). „Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway”. Drugs. 75 (12): 1373—1392. PMC 4532706 . PMID 26201461. S2CID 9612235. doi:10.1007/s40265-015-0437-3. .
Chalasani, Naga P.; Sanyal, Arun J.; Kowdley, Kris V.; Robuck, Patricia R.; Hoofnagle, Jay; Kleiner, David E.; Ünalp, Aynur; Tonascia, James; NASH CRN Research Group (2009). „Pioglitazone versus vitamin e versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design”. Contemporary Clinical Trials. 30 (1): 88—96. PMC 2929909 . PMID 18804555. doi:10.1016/j.cct.2008.09.003.
Dufour, J. F.; Oneta, C. M.; Gonvers, J. J.; Bihl, F.; Cerny, A.; Cereda, J. M.; Zala, J. F.; Helbling, B.; Steuerwald, M.; Zimmermann, A.; Swiss Association for the Study of the Liver (2006). „Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association. 4 (12): 1537—1543. PMID 17162245. doi:10.1016/j.cgh.2006.09.025.
Leuschner, Ulrich F. H.; Lindenthal, Birgit; Herrmann, Günter; Arnold, Joachim C.; Rössle, Martin; Cordes, Hans-Jörg; Zeuzem, Stefan; Hein, Jasper; Berg, Thomas; NASH Study Group (2010). „High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: A double-blind, randomized, placebo-controlled trial”. Hepatology. 52 (2): 472—479. PMID 20683947. S2CID 1472836. doi:10.1002/hep.23727.
Chavez-Tapia, Norberto C.; Tellez-Avila, Felix I.; Barrientos-Gutierrez, Tonatiuh; Mendez-Sanchez, Nahum; Lizardi-Cervera, Javier; Uribe, Misael (2010). „Bariatric surgery for non-alcoholic steatohepatitis in obese patients”. Cochrane Database of Systematic Reviews. 2010 (1): CD007340. PMID 20091629. doi:10.1002/14651858.CD007340.pub2. .
Iwasaki, Tomoyuki; Yoneda, Masato; Inamori, Masahiko; Shirakawa, Jun; Higurashi, Takuma; Maeda, Shin; Terauchi, Yasuo; Nakajima, Atsushi (2011). „Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus”. Hepatogastroenterology. 58 (112): 2103—2105. PMID 22024083. doi:10.5754/hge11263.

easl.eu

DHANJAL, Adonia (2019-09-25). „Obesity epidemic results in Non-Alcoholic Fatty Liver Disease (NAFLD) becoming the most common cause of liver disease in Europe.”. EASL-The Home of Hepatology. (на језику: енглески). Приступљено 2023-01-24.

handle.net

hdl.handle.net

Karkucinska-Wieckowska, Agnieszka; Simoes, Ines C. M.; Kalinowski, Piotr; Lebiedzinska-Arciszewska, Magdalena; Zieniewicz, Krzysztof; Milkiewicz, Piotr; Górska-Ponikowska, Magdalena; Pinton, Paolo; Malik, Afshan N. (2022). „Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship”. European Journal of Clinical Investigation. 52 (3): e13622. ISSN 1365-2362. doi:10.1111/eci.13622. hdl:10316/103977.

harvard.edu

adsabs.harvard.edu

Anderson, Emma L.; Howe, Laura D.; Jones, Hayley E.; Higgins, Julian P. T.; Lawlor, Debbie A.; Fraser, Abigail (2015). „The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis”. PLOS ONE. 10 (10): e0140908. Bibcode:2015PLoSO..1040908A. PMC 4626023 . PMID 26512983. doi:10.1371/journal.pone.0140908 . .

hirurgijadrdjokovic.com

Dr Djoković, Milorad (2021-08-04). „Šta je barijatrijska hirurgija?”. Hirurgija Dr Djoković. Приступљено 2023-01-25.

nih.gov

ncbi.nlm.nih.gov

Eslam, M; Sanyal, AJ; George, J; an international consensus panel. (7. 2. 2020). „MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease.”. Gastroenterology. 158 (7): 1999—2014.e1. PMID 32044314. doi:10.1053/j.gastro.2019.11.312 .
Jensen, Thomas; Abdelmalek, Manal F.; Sullivan, Shelby; Nadeau, Kristen J.; Green, Melanie; Roncol, Carlos; Nakagawa, Takahiko; Kuwabara, Masanari; Sato, Yuka; Kang, Duk-Hee; Tolan, Dean R.; Sanchez-Lozada, Laura G; Rosen, Hugo R.; Lanaspa, Miguel A.; Diehl, Anna Mae; Johnson, Richard J. (2018). „Fructose and Sugar: A Major Mediator of Nonalcoholic Fatty Liver Disease”. HHS Author Manuscripts. 68 (5): 1063—1075. PMC 5893377 . PMID 29408694. doi:10.1016/j.jhep.2018.01.019.
Dulai S., Parambir; Singh, Siddgarth; Petel, Janki; Soni, Meera; Prokop, Larry J.; Younossi, Zobair; Sebastiani, Giada; Ekstedt, Mattias; Hagstrom, Hannes; Nasr, Patrik; Stal, Per; Wong, Vincent Wai-Sun; Kechagias, Stergios; Hultcrantz, Rolf; Loomba, Rohit (2017). „Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: Systematic Review and Meta-analysis”. HHS Author Manuscripts. 65 (5): 1557—1565. PMC 5397356 . PMID 28130788. doi:10.1002/hep.29085.
Anderson, Emma L.; Howe, Laura D.; Jones, Hayley E.; Higgins, Julian P. T.; Lawlor, Debbie A.; Fraser, Abigail (2015). „The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis”. PLOS ONE. 10 (10): e0140908. Bibcode:2015PLoSO..1040908A. PMC 4626023 . PMID 26512983. doi:10.1371/journal.pone.0140908 . .
Estes, Chris; Razavi, Homie; Loomba, Rohit; Younossi, Zobair; Sanyal, Arun J. (2018). „Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease”. Hepatology. 67 (1): 123—133. PMC 5767767 . PMID 28802062. doi:10.1002/hep.29466. .
Hashimoto, Etsuko; Taniai, Makiko; Tokushige, Katsutoshi (2013). „Characteristics and diagnosis of <SCP>NAFLD</SCP>/<SCP>NASH</SCP>”. Journal of Gastroenterology and Hepatology. 28: 64—70. PMID 24251707. S2CID 1986581. doi:10.1111/jgh.12271. .
Ahmed, Monjur (2015). „Non-alcoholic fatty liver disease in 2015”. World Journal of Hepatology. 7 (11): 1450—1459. PMC 4462685 . PMID 26085906. doi:10.4254/wjh.v7.i11.1450 .
Filozof, Claudia; Goldstein, Barry J.; Williams, Richard N.; Sanyal, Arun (2015). „Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway”. Drugs. 75 (12): 1373—1392. PMC 4532706 . PMID 26201461. S2CID 9612235. doi:10.1007/s40265-015-0437-3. .
Chalasani, Naga P.; Sanyal, Arun J.; Kowdley, Kris V.; Robuck, Patricia R.; Hoofnagle, Jay; Kleiner, David E.; Ünalp, Aynur; Tonascia, James; NASH CRN Research Group (2009). „Pioglitazone versus vitamin e versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design”. Contemporary Clinical Trials. 30 (1): 88—96. PMC 2929909 . PMID 18804555. doi:10.1016/j.cct.2008.09.003.
Dufour, J. F.; Oneta, C. M.; Gonvers, J. J.; Bihl, F.; Cerny, A.; Cereda, J. M.; Zala, J. F.; Helbling, B.; Steuerwald, M.; Zimmermann, A.; Swiss Association for the Study of the Liver (2006). „Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association. 4 (12): 1537—1543. PMID 17162245. doi:10.1016/j.cgh.2006.09.025.
Leuschner, Ulrich F. H.; Lindenthal, Birgit; Herrmann, Günter; Arnold, Joachim C.; Rössle, Martin; Cordes, Hans-Jörg; Zeuzem, Stefan; Hein, Jasper; Berg, Thomas; NASH Study Group (2010). „High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: A double-blind, randomized, placebo-controlled trial”. Hepatology. 52 (2): 472—479. PMID 20683947. S2CID 1472836. doi:10.1002/hep.23727.
Chavez-Tapia, Norberto C.; Tellez-Avila, Felix I.; Barrientos-Gutierrez, Tonatiuh; Mendez-Sanchez, Nahum; Lizardi-Cervera, Javier; Uribe, Misael (2010). „Bariatric surgery for non-alcoholic steatohepatitis in obese patients”. Cochrane Database of Systematic Reviews. 2010 (1): CD007340. PMID 20091629. doi:10.1002/14651858.CD007340.pub2. .
Iwasaki, Tomoyuki; Yoneda, Masato; Inamori, Masahiko; Shirakawa, Jun; Higurashi, Takuma; Maeda, Shin; Terauchi, Yasuo; Nakajima, Atsushi (2011). „Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus”. Hepatogastroenterology. 58 (112): 2103—2105. PMID 22024083. doi:10.5754/hge11263.

pubmed.ncbi.nlm.nih.gov

Karkucinska-Wieckowska, Agnieszka; Simoes, Ines C. M.; Kalinowski, Piotr; Lebiedzinska-Arciszewska, Magdalena; Zieniewicz, Krzysztof; Milkiewicz, Piotr; Górska-Ponikowska, Magdalena; Pinton, Paolo; Malik, Afshan N. (2022). „Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship”. European Journal of Clinical Investigation. 52 (3): e13622. ISSN 1365-2362. doi:10.1111/eci.13622. hdl:10316/103977.

semanticscholar.org

api.semanticscholar.org

Hashimoto, Etsuko; Taniai, Makiko; Tokushige, Katsutoshi (2013). „Characteristics and diagnosis of <SCP>NAFLD</SCP>/<SCP>NASH</SCP>”. Journal of Gastroenterology and Hepatology. 28: 64—70. PMID 24251707. S2CID 1986581. doi:10.1111/jgh.12271. .
Filozof, Claudia; Goldstein, Barry J.; Williams, Richard N.; Sanyal, Arun (2015). „Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway”. Drugs. 75 (12): 1373—1392. PMC 4532706 . PMID 26201461. S2CID 9612235. doi:10.1007/s40265-015-0437-3. .
Leuschner, Ulrich F. H.; Lindenthal, Birgit; Herrmann, Günter; Arnold, Joachim C.; Rössle, Martin; Cordes, Hans-Jörg; Zeuzem, Stefan; Hein, Jasper; Berg, Thomas; NASH Study Group (2010). „High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: A double-blind, randomized, placebo-controlled trial”. Hepatology. 52 (2): 472—479. PMID 20683947. S2CID 1472836. doi:10.1002/hep.23727.

wikipedia.org

en.wikipedia.org

Karkucinska-Wieckowska, Agnieszka; Simoes, Ines C. M.; Kalinowski, Piotr; Lebiedzinska-Arciszewska, Magdalena; Zieniewicz, Krzysztof; Milkiewicz, Piotr; Górska-Ponikowska, Magdalena; Pinton, Paolo; Malik, Afshan N. (2022). „Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship”. European Journal of Clinical Investigation. 52 (3): e13622. ISSN 1365-2362. doi:10.1111/eci.13622. hdl:10316/103977.

worldcat.org

Karkucinska-Wieckowska, Agnieszka; Simoes, Ines C. M.; Kalinowski, Piotr; Lebiedzinska-Arciszewska, Magdalena; Zieniewicz, Krzysztof; Milkiewicz, Piotr; Górska-Ponikowska, Magdalena; Pinton, Paolo; Malik, Afshan N. (2022). „Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship”. European Journal of Clinical Investigation. 52 (3): e13622. ISSN 1365-2362. doi:10.1111/eci.13622. hdl:10316/103977.